Your session is about to expire
← Back to Search
Methylphenidate for Normal Brain Function
Study Summary
This trial is studying the brain chemical dopamine and how it is affected by the drug methylphenidate.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- You weigh more than 204 kg (450 lbs).You are allergic to methylphenidate.I have had a head injury that made me unconscious for over 30 minutes.I do not have major health issues affecting my brain function.I am between 18 and 55 years old.I am not pregnant, breastfeeding, and have a negative pregnancy test if of childbearing potential.I can't lie flat on my back for 2 hours.I can avoid certain medications like antibiotics and anti-nausea drugs 24 hours before study procedures.I am not currently using any excluded medications listed, such as strong painkillers, antidepressants, or steroids.I have not binge drunk every month for the last 10 years.I have used stimulants or alcohol but never had an addiction.I have been diagnosed with glaucoma.
- Group 1: 2 Oral PL/IV MP
- Group 2: 3: Oral PL/IV PL
- Group 3: 1:Oral MP- IV PL
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the age limit for participation in this trial above eighty years old?
"Eligibility for this research requires patients to be between 18 and 55 years old. For those outside that age range, there are 8 separate trials available - 1 specifically designed for minors and 7 tailored towards elderly citizens."
Are there still vacancies in this clinical investigation?
"The clinical trial entry hosted on the official trials registry states that this particular study is not actively recruiting candidates at present. The information was last updated in July 2022, however there are currently 16 other studies searching for participants."
Have the Food and Drug Administration granted approval for a 2 Oral PL/IV MP regimen?
"As this is an early-stage Phase 1 trial, little data exists to support its safety and efficacy. Due to this fact, our team has provisionally ranked 2 Oral PL/IV MP a 1 on the risk scale."
May I be included in the sampling for this investigation?
"This trial is recruiting 40 individuals aged 18-55 who possess pristine physiological characteristics. In addition, applicants must be willing to abstain from any drug use on scheduled testing days and have no prior experience with alcohol or stimulant drugs such as cocaine, methylphenidate, amphetamine or methamphetamine, diet pills (prescription or over the counter), caffeine and other substances but not a substance use disorder. Males and females are both eligible for enrollment in this study."
Share this study with friends
Copy Link
Messenger